The greatest challenges in combination product development stem from differences and misunderstandings between drug and device manufacturers. The two industries have different cultures, paradigms, regulations, procedures, safety concerns, evidence requirements, timelines, budgets, and vocabularies. This conference brings together senior experts from drug and device companies and from FDA to focus on those pre- and postmarket areas where disconnects between the two parties cause the most delays, cost overruns, and failures.

Fill out the form below, and we will make sure you're the first to know when we open up registration for this conference.